New combo therapy aims to fight childhood obesity
NCT ID NCT04520490
First seen Jan 05, 2026 · Last updated Jun 12, 2026 · Updated 28 times
Summary
This study looks at whether adding a weekly medicine (exenatide) to family-based behavioral therapy helps children ages 10-12 with obesity lose more weight. About 63 children will take part, and researchers will track changes in body mass index and body composition. The goal is to improve long-term weight control and reduce health risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.